Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Total Liabilities (2016 - 2026)

Oramed Pharmaceuticals filings provide 15 years of Total Liabilities readings, the most recent being $31.1 million for Q4 2025.

  • Quarterly Total Liabilities rose 213.36% to $31.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Dec 2025, up 213.36% year-over-year, with the annual reading at $31.1 million for FY2025, 213.36% up from the prior year.
  • Total Liabilities hit $31.1 million in Q4 2025 for Oramed Pharmaceuticals, up from $17.2 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $82.7 million in Q3 2023 and bottomed at $5.7 million in Q2 2023.
  • Average Total Liabilities over 5 years is $18.7 million, with a median of $10.9 million recorded in 2022.
  • The largest annual shift saw Total Liabilities surged 632.18% in 2023 before it tumbled 88.44% in 2024.
  • Oramed Pharmaceuticals' Total Liabilities stood at $12.3 million in 2021, then decreased by 14.71% to $10.5 million in 2022, then soared by 449.86% to $57.7 million in 2023, then crashed by 82.78% to $9.9 million in 2024, then skyrocketed by 213.36% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for ORMP's Total Liabilities are $31.1 million (Q4 2025), $17.2 million (Q3 2025), and $8.1 million (Q2 2025).